Peripheral electric stimulation attenuates the expression of cocaine-induced place preference in rats

Brain Research

Volumn 957, Issue 1, 2002, Pages 129-135

  Ren, Yan Hua ^a   Wang, Bin ^a   Luo, Fei ^a   Cui, Cai Lian ^a   Zheng, Ji Wang ^a   Han, Ji sheng ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Cocaine; Conditioned place preference; Craving; Opioid; Peripheral electric stimulation; Reward

Indexed keywords

COCAINE; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; FREQUENCY MODULATION; MALE; NONHUMAN; OUTCOMES RESEARCH; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECORDING; TIME;

ANIMALS; COCAINE; CONDITIONING (PSYCHOLOGY); CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 0037032681     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03614-4     Document Type: Article

References (32)

1. Barak Caine S., Koob G.F. Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J. Exp. Anal. Behav. 61:1994;213-221.
2. Bilsky E.J., Montegut M.J., Delon C.L., Reid L.D. Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50:1992;185-190.
3. Bian J.T., Sun M.Z., Han J.S. Reversal of electroacupuncture tolerance by CCK-8 antiserum: an electrophysiological study on pain-related neurons in nucleus parafascicularis of the rat. Int. J. Neurosci. 72:1993;15-29.
4. Chen X.H., Han J.S. Analgesia induced by electroacupuncture of different frequencies is mediated by different types of opioid receptors: another cross-tolerance study. Behav. Brain Res. 47:1992;143-149.
5. Gerrits M.A., Patkina N., Zvartau E.E., Van Ree J.M. Opioid blocked attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology. 119:1995;92-98.
6. Goldstein A., Tachibana S., Lowney L.I., Humkapillar M., Hood L. Dynorphin (1-13): an extraordinary potent opioid peptide. Proc. Natl. Acad. Sci. USA. 76:1979;6666-6670.
7. Guo H.F., Tian J.H., Wang X.M., Fang H., Huo Y., Han J.S. Brain substrates activated by electroacupuncture of different frequencies (I): comparative stud on the expression of oncogene c-fos and genes coding for three opioid peptides. Mol. Brain Res. 43:1996;157-166.
8. Guo H.F., Tian J.H., Wang X.M., Fang Y., Hou Y.P., Han J.S. Brain substrates activated by electroacupuncture (EA) of different frequencies (II): Role of Fos/Jun proteins in EA-induced transcription of preproenkephalin and preprodynorphin genes. Mol. Brain Res. 43:1996;167-173.
9. Han J.S., Zhang R.L. Suppression of morphine abstinence syndrome by body electroacupuncture of different frequencies in rats. Drug Alcohol Depend. 31:1993;169-175.
10. Han Z., Jiang Y.H., Wan Y., Wang Y., Chang J.K., Han J.S. Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat. Neurosci. Lett. 274:1999;75-78.
11. Hiramatsu M., Hyodo T., Kameyama T. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Eur. J. Pharmacol. 315:1996;119-125.
12. Hiramatsu M., Inoue K., Kameyama T. Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice. Neuroreport. 11:2000;431-435.
13. Hiramatsu M., Sasaki M., Nabeshima T., Kameyama T. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol. Biochem. Behav. 56:1997;73-79.
14. Itoh J., Ukai M., Kameyama T. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice. Brain Res. 619:1993;223-228.
15. Itzhak Y., Martin J.L. Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants. Neuropsychopharmacology. 26:2002;130-134.
16. Kuzmin A.V., Gerrits M.A., Van Ree J.M. Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naïve rats. Eur. J. Pharmacol. 358:1998;197-202.
17. Moron J.A., Rea W., Shippenberg T.S. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience. 101:2000;619-627.
18. Mueller D., Stewart J. Cocaine-induced place preference: reinstatement by priming injections of cocaine after extinction. Behav. Brain Res. 115:2000;39-47.
19. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2:2001;119-128.
20. Reid L.D., Glick S.D., Menkens K.A., French E.D., Bilsky E.J., Porreca F. Cocaine self-administration and naltrindole, a delta-selective opioid antagonist. Neuroreport. 6:1995;1409-1412.
21. Schenk S., Partridge B. Effect of the kappa-opioid receptor agonist, U69593, on reinforcement of extinguished amphetamine self-administration behavior. Pharmacol. Biochem. Behav. 68:2001;629-634.
22. Shippenberg T.S., Zapata A., Heidbreder C.A. Modulation of the behavioral and neurochemical effects of psychostimulants by κ-opioid receptor systems. Ann. N.Y. Acad. Sci. 937:2001;50-73.
23. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA. 89:1992;2046-2050.
24. Thompson A.C., Zapata A. Jr., Justice J.B., Vaughan R.A., Sharpe L.G., Shippenberg T.S. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effect of cocaine. J. Neurosci. 20:2000;9333-9340.
25. Thompson A.C., Shippenberg T.S. Modulation of cocaine-induced sensitization by κ-opioid receptor agonists. Ann. N.Y. Acad. Sci. 887:1999;803-806.
26. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56:1998;613-672.
27. Ukai M., Itoh J., Kobayashi T., Shinkai N., Kameyama T. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice. Behav. Brain Res. 83:(1-2):1997;169-172.
28. Ukai M., Kobayashi T., Shinkai N., Shan-Wu X., Kameyama T. Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice. Eur. J. Pharmacol. 274:1995;89-93.
29. Wang B., Luo F., Xia Y.Q., Han J.S. Peripheral electric stimulation inhibits morphine-induced place preference in rats. Neuroreport. 11:2000;1017-1020.
30. Wood P.L., Stotland M., Richard J.W., Rackham A. Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J. Pharmacol. Exp. Ther. 215:1980;697-703.
31. Wu L.Z., Cui C.L., Tian J.B., Ji D., Han J.S. Suppression of morphine withdrawal by electroacupuncture in rats: dynorphin and κ-opioid receptor implicated. Brain Res. Interact. 851:1999;290-296.
32. Wu L.Z., Cui C.L., Han J.S. Treatment on heroin addicts by four channel Han's acupoint nerve stimulator (HANS). J. Beijing Med. Univers. 31:(3):1999;239-242.